Global Registry for Cardiorenal and Metabolic Diseases
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 35,000 (estimated)
- Sponsor
- AstraZeneca · Industry
This trial is looking for adults with type 2 diabetes, hypertension, heart failure, or chronic kidney disease. Participants will provide information about their health and treatment to help improve patient care.
You may be able to join if
- I am 18 years or older
- I have type 2 diabetes
- I have hypertension
- I have heart failure
- I have chronic kidney disease
- I can provide written informed consent
You may not be able to join if
- I have a life-threatening illness with a life expectancy below 1 year
- I am participating in another clinical trial that requires consent
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityTo provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Loading trial locations…
AstraZeneca Clinical Study Information Center
1-877-240-9479
information.center@astrazeneca.com
CONTACT